Truist Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Truist Financial’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-19,728	Closed	-$454K	–	2671
2023 Q4	$454K	Sell	19,728 -2,493	-11%	-$50.1K	﹤0.01%	2043
2023 Q3	$452K	Sell	22,221 -388	-2%	-$8.71K	﹤0.01%	1973
2023 Q2	$528K	Sell	22,609 -712	-3%	-$17.1K	﹤0.01%	1921
2023 Q1	$543K	Buy	23,321 +4,702	+25%	+$118K	﹤0.01%	1930
2022 Q4	$469K	Buy	+18,619	New	+$500K	﹤0.01%	2007

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Truist Financial's IDNA Position: Q1 2024 in Review

Truist Financial sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2024, closing a stake of 19,728 shares — an estimated $454K sold.

Truist Financial first reported a position in IDNA in Q4 2022 and held it in 5 quarters. The position peaked at $543K in Q1 2023. 63 funds tracked by Wall St. Rank hold IDNA as of Q1 2024.

Truist Financial reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2024 after selling out during the quarter.
Truist Financial sold 19,728 iShares Genomics Immunology and Healthcare ETF shares in Q1 2024, an estimated $454K.
Truist Financial first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2022 and held it in 5 quarters.
Truist Financial's iShares Genomics Immunology and Healthcare ETF position peaked at $543K in Q1 2023.
63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2024.

Based on Truist Financial's 13F filing for Q1 2024, filed 13 May 2024.